AI-Driven Precision Medicine: Comprehensive Applications in Disease Prediction, Personalized Treatment, and Drug Discovery
Kexin Yu , Jun Jiang , Zhigang Jiang , Jiangjiao Liu , Roy Rillera Marzo
Artificial Intelligence and Medicine ›› 2025, Vol. 1 ›› Issue (1) : 18 -27.
This review explores AI’s transformative role in precision medicine, focusing on disease prediction, personalized treatment, and drug discovery. In disease prediction, AI uses EHRs, imaging, and multi-omics data to stratify risks: XGBoost outperforms traditional models in CVD risk prediction; deep learning enhances early cancer detection (e.g., oral cancer via histopathology images); multi-omics integration aids neurodegenerative disease forecasting; and GCNs predict infectious outbreaks via real-time keyword analysis. For personalized treatment, AI tailors strategies: it analyzes genomic profiles to guide cancer therapy (e.g., identifying HER2 activation in CDK4/6i-resistant breast cancer); PK/PD modeling optimizes drug dosages (e.g., rituximab in nephropathy); it refines clinical trial patient selection (e.g., ASM choice for epilepsy); improves mental health diagnosis/treatment; and designs personalized stroke rehabilitation via wearable sensor data. In drug discovery, AI accelerates the pipeline: it identifies targets (e.g., SSO binding sites in triple-negative breast cancer); virtual screening (e.g., DeepDock for JAK3 inhibitors) and de novo design (e.g., CLMs for PI3Kγ inhibitors) find lead compounds; MIFAM-DTI predicts drug-target interactions; AI optimizes clinical trial design; and it enables drug repurposing (e.g., identifying fibrosis-related drugs via EHRs). Key challenges include data privacy (addressed via blockchain/SecPri-BGMPOP), algorithmic bias (needing diverse datasets), explainable AI (critical for CDSS trust), and multi-omics integration. AI-driven precision medicine promises proactive, personalized healthcare, requiring collaboration across stakeholders for ethical implementation.
artificial intelligence / disease prediction / personalized treatment / drug discovery
| [1] |
Dr. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
Backyard flock sampling and artificial intelligence: A dual strategy for early detection of Avian Influenza and Newcastle Disease, German Journal of Veterinary Research, 2024. |
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
/
| 〈 |
|
〉 |